phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000287.v6.p1 Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs001584.v1.p1 eMERGE Network Phase III: HRC Imputed Array Data of 83,000+ Participants | Version 1: passed embargo
| VDAS | 83717 | Case-Control | | Nimblegen Custom SeqCap
|
phs000888.v1.p1 eMERGE Network Imputed GWAS for 41 phenotypes | Version 1: passed embargo
| VDAS | 55029 | Case-Control, Cohort | Links | 1000 Genomes
|
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000309.v3.p2 The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000236.v2.p2 PAGE: CALiCo: Coronary Artery Risk Development in Young Adults(CARDIA) | Versions 1-2: passed embargo
| VDAS | 3595 | Longitudinal | Links | TaqMan OpenArrays: CALiCo ABD TaqMan Y1 TaqMan OpenArrays: CALiCo ABD TaqMan Y2 TaqMan OpenArrays: CALiCo AOD TaqMan Y1 TaqMan OpenArrays: CALiCo AOD TaqMan Y2 TaqMan OpenArrays: CALiCo DME TaqMan Y1 TaqMan OpenArrays: CALiCo DME TaqMan Y2 TaqMan OpenArrays: CALiCo Sequenom Y2 iSelect Custom Panel
|
phs001293.v1.p1 NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy | Version 1: passed embargo
| VDAS | 2104 | Family | | HiSeq X Ten
|
phs000286.v6.p2 The Jackson Heart Study (JHS) | Versions 1-6: passed embargo
| VDAS | 3889 | Cohort | | HiSeq X Ten
|
phs001575.v1.p1 Assessment of Neurological Deterioration in Subjects with LINCL | Version 1: passed embargo
| VDAS | 42 | Longitudinal | | |
phs001331.v2.p1 Immune Mediated Disorders after Allo-HCG | Version 1: passed embargo Version 2: 2019-09-16
| VDAS | 1023 | Longitudinal | Links | |
phs000391.v1.p1 Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study | Version 1: passed embargo
| VDAS | 666 | Interventional | Links | Mapping250K_Nsp Mapping250K_Sty AFFY_6.0
|
phs000378.v1.p1 Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia | Version 1: passed embargo
| VDAS | 1251 | Community, Longitudinal, Cross-Sectional | Links | HumanOmni2.5
|
phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS) | Versions 1-3: passed embargo
| VDAS | 4757 | Case-Control | Links | ILMN_Human-1 Mapping50K_Hind240 Mapping50K_Xba240
|
phs001288.v1.p1 Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC) | Version 1: passed embargo
| VDAS | 264 | Longitudinal | Links | |